Karyopharm Therapeutics | KPTI - 유동 자산





유동 자산 변화 날짜
AbbVie USD 33.67B 140M 2026-06
Abbott USD 25.51B 488M 2026-03
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
GlaxoSmithKline GBP 17.56B 202M 2026-06
Incyte USD 6.03B 542.31M 2026-06
J&J USD 59.77B 601M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 27.35B 744M 2026-06
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Takeda JPY 3.15T 59.77B 2026-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
TG Therapeutics USD 1.15B 58.72M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Xencor USD 523.21M 40.36M 2026-06